Chemistry: analytical and immunological testing – Biospecific ligand binding assay
Patent
1997-04-02
1999-08-24
Saunders, David
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
436178, 436518, 436533, 436534, 436535, 436807, 436815, 436822, 436824, G01N 33543, G01N 33546, G01N 33547
Patent
active
059424427
ABSTRACT:
Apparatus and method for detection of low levels of about 1 ppb of analyte in samples using an enclosed permeable membrane enrichment device and agglutination reaction slide test apparatus.
REFERENCES:
patent: 4596695 (1986-06-01), Cottingham
patent: 4597944 (1986-07-01), Cottingham
patent: 4775515 (1988-10-01), Cottingham
patent: 5019351 (1991-05-01), Schulz
patent: 5236826 (1993-08-01), Marshall
patent: 5501949 (1996-03-01), Marshall
patent: 5552325 (1996-09-01), Nochumson et al.
"Screening for Drugs of Abuse with the Roche ONTRAK Assays", Journal of Analytical Toxicology, vol. 16, May/Jun. 1992.
"3M Empore.TM., Strontium Rad Disks", IBC Advanced Technologies, Inc., 1995.
"Protrans.TM. Affinity Disks", ICN Biomedicals, Inc.
Di Cesare Joseph L.
Rosen Steven M.
Rauchfuss, Jr. George W.
Roche Dianostic Systems, Inc.
Saunders David
The Perkin-Elmer Corporation
LandOfFree
Detection of low level analytes in samples using agglutination r does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of low level analytes in samples using agglutination r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of low level analytes in samples using agglutination r will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-466848